Biophytis (BPTSY) Competitors $3.05 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends BPTSY vs. BNOX, RNAZ, ALZN, ORGS, LIXT, ADTX, ALLR, GRAY, OGEN, and SILOShould you be buying Biophytis stock or one of its competitors? The main competitors of Biophytis include Bionomics (BNOX), TransCode Therapeutics (RNAZ), Alzamend Neuro (ALZN), Orgenesis (ORGS), Lixte Biotechnology (LIXT), Aditxt (ADTX), Allarity Therapeutics (ALLR), Graybug Vision (GRAY), Oragenics (OGEN), and Silo Pharma (SILO). These companies are all part of the "pharmaceutical preparations" industry. Biophytis vs. Bionomics TransCode Therapeutics Alzamend Neuro Orgenesis Lixte Biotechnology Aditxt Allarity Therapeutics Graybug Vision Oragenics Silo Pharma Bionomics (NASDAQ:BNOX) and Biophytis (NASDAQ:BPTSY) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability, media sentiment and community ranking. Does the MarketBeat Community favor BNOX or BPTSY? Bionomics received 20 more outperform votes than Biophytis when rated by MarketBeat users. CompanyUnderperformOutperformBionomicsOutperform Votes2076.92% Underperform Votes623.08% BiophytisN/AN/A Which has more risk & volatility, BNOX or BPTSY? Bionomics has a beta of 0.27, meaning that its share price is 73% less volatile than the S&P 500. Comparatively, Biophytis has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500. Do insiders & institutionals have more ownership in BNOX or BPTSY? 15.9% of Bionomics shares are owned by institutional investors. Comparatively, 0.1% of Biophytis shares are owned by institutional investors. 0.7% of Bionomics shares are owned by insiders. Comparatively, 3.7% of Biophytis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has better valuation and earnings, BNOX or BPTSY? Bionomics has higher revenue and earnings than Biophytis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBionomics$10K428.82-$15.49MN/AN/ABiophytisN/AN/A-$18.43MN/AN/A Do analysts rate BNOX or BPTSY? Bionomics currently has a consensus price target of $8.00, suggesting a potential upside of 3,193.54%. Given Bionomics' stronger consensus rating and higher possible upside, research analysts clearly believe Bionomics is more favorable than Biophytis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bionomics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Biophytis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is BNOX or BPTSY more profitable? Company Net Margins Return on Equity Return on Assets BionomicsN/A N/A N/A Biophytis N/A N/A N/A Does the media prefer BNOX or BPTSY? In the previous week, Bionomics had 4 more articles in the media than Biophytis. MarketBeat recorded 4 mentions for Bionomics and 0 mentions for Biophytis. Bionomics' average media sentiment score of 0.57 beat Biophytis' score of 0.00 indicating that Bionomics is being referred to more favorably in the media. Company Overall Sentiment Bionomics Positive Biophytis Neutral SummaryBionomics beats Biophytis on 9 of the 11 factors compared between the two stocks. Ad ProsperityPubThis Indicator called BOTH NVDA ralliesRarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTSY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BPTSY vs. The Competition Export to ExcelMetricBiophytisPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.07M$6.57B$5.14B$9.08BDividend YieldN/A2.99%5.09%4.23%P/E RatioN/A10.5990.0517.18Price / SalesN/A196.061,116.25117.05Price / CashN/A57.1643.1037.85Price / Book-0.195.094.784.78Net Income-$18.43M$151.83M$120.31M$225.60M7 Day Performance-16.44%-2.14%-1.92%-1.23%1 Month Performance6.64%-4.56%13.65%0.46%1 Year PerformanceN/A8.87%28.34%15.24% Biophytis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BPTSYBiophytisN/A$3.05flatN/AN/A$1.07MN/A0.0022BNOXBionomics2.517 of 5 stars$0.29-11.8%$8.00+2,707.0%-81.3%$5.03M$10,000.000.00N/ARNAZTransCode Therapeutics2.9597 of 5 stars$7.12-4.0%$99.00+1,290.4%-99.9%$4.98MN/A0.009Analyst ForecastAnalyst RevisionNews CoveragePositive NewsALZNAlzamend Neuro2.6259 of 5 stars$1.25+5.0%$32.00+2,460.0%-87.7%$4.86MN/A0.004News CoveragePositive NewsORGSOrgenesisN/A$0.98-4.4%N/AN/A$4.68M$530,000.000.00150News CoverageLIXTLixte BiotechnologyN/A$2.01+1.3%N/A-10.4%$4.52MN/A-1.153Positive NewsGap UpADTXAditxt0.6214 of 5 stars$0.31-10.1%N/A-99.9%$4.45M$640,000.000.0047ALLRAllarity Therapeutics0.0696 of 5 stars$0.98-4.4%N/A-99.7%$4.32MN/A0.005News CoverageGRAYGraybug VisionN/A$2.73-2.2%N/A-10.0%$4.29MN/A-0.1127High Trading VolumeOGENOragenicsN/A$0.34+2.7%N/AN/A$4.14M$40,000.000.005Analyst ForecastNews CoverageGap UpSILOSilo Pharma0.6696 of 5 stars$0.91+9.0%N/A-44.1%$4.08M$70,000.000.003News CoveragePositive News Related Companies and Tools Related Companies Bionomics Alternatives TransCode Therapeutics Alternatives Alzamend Neuro Alternatives Orgenesis Alternatives Lixte Biotechnology Alternatives Aditxt Alternatives Allarity Therapeutics Alternatives Graybug Vision Alternatives Oragenics Alternatives Silo Pharma Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BPTSY) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biophytis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biophytis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BPTSY Stock Alerts